Capping SUNY Downstate Medical Center's growth into a major center for eye research, Research to Prevent Blindness (RPB) has awarded SUNY Downstate a four-year challenge grant of $220,000 to spur the development of advanced research into the causes, treatment, and prevention of blinding diseases. Douglas R. Lazzaro, MD, professor and chair of ophthalmology, is the principal investigator. RPB is the world's leading voluntary organization supporting eye research.
"This award from RPB is a major milestone in the development of an ophthalmology research nucleus at SUNY Downstate," said Dr. Lazzaro. SUNY Downstate is now one of 52 institutions receiving this recognition from RPB, which, since its founding in 1960, has channeled hundreds of millions of dollars to medical institutions throughout the United States. In the last five years, Downstate has attracted $6.2 million in eye research funding from various sources.
Dr. Lazzaro's team includes William J. Brunken, PhD, professor of cell biology and ophthalmology and director of ophthalmic research, who is studying the role of the extracellular matrix in retinal development and disease; and John Danias, MD, PhD, professor of cell biology and ophthalmology, who is elucidating the molecular basis of glaucoma and evaluating potential new treatment strategies.
In addition, another member of the team, Brahim Chaqour, PhD, associate professor of cell biology and ophthalmology at Downstate, has been awarded a National Eye Institute grant for research on neovascularization in the retina. Jacob Aranda, MD, PhD, professor of pediatrics and ophthalmology and director of neonatology, was awarded a major grant from the National Institute of Child Health and Human Development to establish a pediatric pharmacology center focused on research to prevent retinopathy of prematurity.
Dr. Lazzaro and Dr. Brunken have also received an Empire Clinical Research Investigator Program (ECRIP) fellowship
|Contact: Ron Najman|
SUNY Downstate Medical Center